What is the current price / NAV of Tata India Pharma & Healthcare Fund(IDCW)?
The current NAV of Tata India Pharma & Healthcare Fund(IDCW) is ₹34.81, as of 12th June 2025.What are the returns of Tata India Pharma & Healthcare Fund(IDCW)?
The Tata India Pharma & Healthcare Fund(IDCW) was launched on 28th December 2015. This mutual fund's past returns are as follows:- 1 Year Returns: 16.21%
- 3 Year Returns: 26.15%
- 5 Year Returns: 23.42%
What are the top 5 sectoral holdings of Tata India Pharma & Healthcare Fund(IDCW)?
The top sectors Tata India Pharma & Healthcare Fund(IDCW) has invested in are as follows:- Pharmaceuticals | 60.37%
- Labs & Life Sciences Services | 26.25%
- Others | 11.17%
- Fertilizers & Agro Chemicals | 1.12%
- IT Services & Consulting | 0.51%
What are the top 5 holdings of Tata India Pharma & Healthcare Fund(IDCW)?
The top 5 holdings for Tata India Pharma & Healthcare Fund(IDCW) are as follows:- Sun Pharmaceutical Industries Ltd | 11.64%
- CASH / NET CURRENT ASSET | 8.92%
- Apollo Hospitals Enterprise Ltd | 6.22%
- Cipla Ltd | 5.83%
- Aurobindo Pharma Ltd | 5.73%
What is the asset allocation of Tata India Pharma & Healthcare Fund(IDCW)?
The asset allocation for Tata India Pharma & Healthcare Fund(IDCW) is as follows:- Equity | 90.84%
- Cash & Equivalents | 9.16%
What is the AUM of Tata India Pharma & Healthcare Fund(IDCW)?
The AUM (i.e. assets under management) of Tata India Pharma & Healthcare Fund(IDCW) is ₹1231.67 Cr as of 12th June 2025.What is the expense ratio of Tata India Pharma & Healthcare Fund(IDCW)?
The expense ratio of Tata India Pharma & Healthcare Fund(IDCW) Plan is 0.63 as of 12th June 2025.What is the alpha ratio of Tata India Pharma & Healthcare Fund(IDCW)?
The alpha ratio for the Tata India Pharma & Healthcare Fund(IDCW) is 2.04
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of Tata India Pharma & Healthcare Fund(IDCW)?
The volatility or standard deviation for the Tata India Pharma & Healthcare Fund(IDCW) is 15.29
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of Tata India Pharma & Healthcare Fund(IDCW)?
The Sharpe ratio for the Tata India Pharma & Healthcare Fund(IDCW) is 0.80
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of Tata India Pharma & Healthcare Fund(IDCW)?
The Sortino Ratio for the Tata India Pharma & Healthcare Fund(IDCW) is 0.08
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of Tata India Pharma & Healthcare Fund(IDCW)?
The PE ratio of Tata India Pharma & Healthcare Fund(IDCW) is 50.92, while category PE ratio is 53.39.
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%